Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting

Objective: Suvorexant is an orexin receptor antagonist and is effective in inducing sleep. We hypothesized that Suvorexant would reduce the incidence of postoperative delirium (POD) after coronary artery bypass grafting (CABG). Methods: We reviewed 88 patients (12 women, mean age: 69.3 ± 2.5 years)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Kiyoshi, Maruyama, Toshiyuki, Sakurai, Syogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388307/
https://www.ncbi.nlm.nih.gov/pubmed/30089761
http://dx.doi.org/10.5761/atcs.oa.18-00038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388307/
https://www.ncbi.nlm.nih.gov/pubmed/30089761
http://dx.doi.org/10.5761/atcs.oa.18-00038

Ejemplares similares